Abstract:Risk assessment has become increasingly important in this era of evidence-based medicine in which new and existing technology requires a well-defined body of evidence on its societal benefit in order to support resource utilization. Historically, test accuracy has been defined by using sensitivity and specificity for the detection of obstructive coronary disease. However, this measurement is fraught with bias and poorly reflects test performance. The focus on risk assessment in cardiovascular medicine is consistent with a shift toward integrative patient management approaches whereby the extent and severity of inducible ischemia are used to guide therapeutic decision making. This change in focus allows nuclear cardiology to play a central role in patient management decisions. The estimation of prognosis with any given imaging modality allows a more precise linkage with patient risk and therapeutic risk reduction efforts. In addition, a nuclear-based focus for decision making concentrates on the physiologic significance of the disease state and its relationship to event risk. This concept of medically guided care (including optimized anti-ischemic therapy and selective cardiac catheterization) is further promoted in our current era of cost-conscious health care. From nuclear-based strategies that provide information about patient risk, the ensuing posttest resource needs of any given patient group may also be estimated. The ensuing costs for tests that have established value in identifying prognostically significant disease states may be offset by the downstream savings in decreased morbidity and mortality. In the United States, annual expenditures for diagnosing and treating cardiovascular disease exceed $329 billion. Health care costs have risen dramatically and exceed the rate of inflation. Although rising costs reflect an increase in the prevalence of coronary heart disease and an aging population, new technology for cardiovascular disease is also a major contributor to high rates of resource utili-

Sensitive Determination of Parabens in Soy Sauces by Capillary Zone Electrophoresis with Amperometric Detection

Simultaneous Determination of Phthalates and Parabens in Cosmetic Products by Gas Chromatography/Mass Spectrometry Coupled with Solid Phase Extraction

Online preconcentration in capillary electrophoresis with contactless conductivity detection for sensitive determination of sorbic and benzoic acids in soy sauce.

Determination of 7 Nipagin Ester Preservatives in Leather by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Coupled with Gel Permeation Chromatographic Clean-Up

Optimization of Determination Condition for Flavor Compounds in Soy Sauce by SPME-GC

A rapid and environmentally friendly method for determination of parabens preservatives in flavors by supercritical fluid chromatography-tandem mass spectrometry

MAJOR ACHIEVEMENTS IN NUCLEAR CARDIOLOGY : III Prognostic value of gated myocardial perfusion SPECT

Determination of paraben preservatives in seafood using matrix solid-phase dispersion and on-line acetylation gas chromatography-mass spectrometry

[Determination of Multiple Chloropropanols in Soy Sauce by Dispersive Solid Phase Extraction-Gas Chromatography-High Resolution Mass Spectrometry].

Comparative Study for the Analysis of Parabens by Micellar Electrokinetic Capillary Chromatography with and Without Large-Volume Sample Stacking Technique.

Studies on malarial parasites; the staining of two primate parasites by the Feulgen technique.

Simultaneous determination of preservatives (benzoic acid, sorbic acid, methylparaben and propylparaben) in foodstuffs using high-performance liquid chromatography

Matrix solid-phase dispersion combined to liquid chromatography-tandem mass spectrometry for the determination of paraben preservatives in mollusks

Application of dispersive liquid–liquid extraction followed by rapid and direct mass spectrometry analysis to evaluate parabens in high salinity water sample

Ultrasound-assisted Dispersive Liquid-Liquid Microextraction Followed by Gas Chromatography–mass Spectrometry for Determination of Parabens in Human Breast Tumor and Peripheral Adipose Tissue

[Rapid Determination of 18 Amino Acids in Soy Sauce by Ultra-Performance Liquid Chromatography with Pre-Column Derivatization].

Application of Dispersive Liquid-Liquid Extraction Followed by Rapid and Direct Mass Spectrometry Analysis to Evaluate Parabens in Seawater

Determination of parabens in breast milk using stir bar sorptive extraction coupled with UHPLC-UV

Improved analysis of 230 pesticide residues in three fermented soy products by using automated one-step accelerated solvent extraction coupled with GC-MS/MS

Determination of Nε-(1-Carboxymethyl)-L-Lysine in brewing soy sauce by ultrahigh performance liquid chromatography coupled with tandem mass spectrometry

Determination of 3-Mono-chloropropane-1,2-diol in Soy Sauce by Solid Phase Extraction with Gas Chromatography-Mass Spectrometry